Finance

Lists
Why is LOBEF down 28,46%?
Dive Deeper
LOBEF:OTCMKTS
Lobe Sciences Ltd
USD 0,036
-28,46%
(-0,014) 1D
9 Okt., 12:36:59 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LOBEF...
Open
USD 0,03
High
USD 0,04
Low
USD 0,03
Mkt. cap
16,68 m
Avg. vol.
68,74 k
Volume
6,90 k
52-wk high
USD 0,11
52-wk low
USD 0,02
Beta
0,47
Shares outstanding
308,18 m
Open
USD 0,03
High
USD 0,04
Low
USD 0,03
Mkt. cap
16,68 m
Avg. vol.
68,74 k
Volume
6,90 k
52-wk high
USD 0,11
52-wk low
USD 0,02
Beta
0,47
Shares outstanding
308,18 m
News stories
From web sources and news partners
About Lobe Sciences Ltd
CEO-
Employees-
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitelobesciences.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Aug. 2025
Nov. 2025
Feb. 2026
Mei 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
339,20 k
982,09 k
1,13 m
331,74 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,24 m
337,43 k
949,41 k
703,56 k
Operating expense
1,85 m
1,45 m
2,39 m
1,18 m
Total operating expenses
1,85 m
1,45 m
2,39 m
1,18 m
Operating income
-1,85 m
-1,45 m
-2,39 m
-1,18 m
Other non operating income
-782,90 k
67,97 k
-30,02 k
10,73 k
EBT including unusual items
-2,22 m
-1,31 m
-2,39 m
-1,14 m
EBT excluding unusual items
-2,43 m
-1,31 m
-2,39 m
-1,14 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,94 m
-916,14 k
-1,78 m
-529,60 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
185,20 k
75,90 k
53,39 k
51,26 k
Interest expense
-
-18,14 k
-17,11 k
-18,21 k
Net interest expenses
185,20 k
57,76 k
36,28 k
33,06 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,83 m
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme